Cargando…
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Autores principales: | Montero-Escribano, Paloma, Matías-Guiu, Jorge, Gómez-Iglesias, Patricia, Porta-Etessam, Jesús, Pytel, Vanesa, Matias-Guiu, Jordi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204643/ https://www.ncbi.nlm.nih.gov/pubmed/32408147 http://dx.doi.org/10.1016/j.msard.2020.102185 |
Ejemplares similares
-
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
por: Matías-Guiu, Jorge, et al.
Publicado: (2020) -
Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis
por: Torre‐Fuentes, Laura, et al.
Publicado: (2020) -
Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2021) -
Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
por: Pytel, Vanesa, et al.
Publicado: (2019) -
Structural MRI correlates of PASAT performance in multiple sclerosis
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)